(Q72312892)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7781147%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

title

The effects of oral 4-hydroxyandrostenedione on peripheral aromatisation in post-menopausal breast cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7781147%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

4

P E Lonning

1 reference

25 October 2019

F A MacNeill

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7781147%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

S Jacobs

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7781147%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

M Dowsett

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7781147%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

T J Powles

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7781147%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

publication date

1 January 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7781147%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

25 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7781147%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7781147%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7781147%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

page(s)

249-254

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7781147%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00685855

25 October 2019

exact match

0 references

1 reference

12 December 2020

Aminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*

1 reference

12 December 2020

Clinical development of aromatase inhibitors for the treatment of breast and prostate cancer

1 reference

12 December 2020

Comparison of the pharmacokinetics and pharmacodynamics of unformulated and formulated 4-hydroxyandrostenedione taken orally by healthy men

1 reference

12 December 2020

An endocrine and pharmacokinetic study of four oral doses of formestane in postmenopausal breast cancer patients

1 reference

12 December 2020

The influence of aminoglutethimide and its analogue rogletimide on peripheral aromatisation in breast cancer

1 reference

12 December 2020

The influence of CGS 16949A on peripheral aromatisation in breast cancer patients

1 reference

12 December 2020

Potency and selectivity of the non-steroidal aromatase inhibitor CGS 16949A in postmenopausal breast cancer patients

1 reference

12 December 2020

Measurement of Aromatisation by a Urine Technique Suitable for the Evaluation of Aromatase Inhibitorsin Vivo

1 reference

12 December 2020

Plasma and urinary oestrogens in breast cancer patients on treatment with 4-hydroxyandrostenedione

1 reference

12 December 2020

Separation of urinary metabolites of radiolabelled estrogens in man by HPLC.

1 reference

12 December 2020

Aminoglutethimide as treatment of postmenopausal women with advanced breast carcinoma

1 reference

12 December 2020

Oral 4-hydroxyandrostenedione, a new endocrine treatment for disseminated breast cancer

1 reference

12 December 2020

Postmenopausal estrogen synthesis and metabolism: alterations caused by aromatase inhibitors used for the treatment of breast cancer

1 reference

12 December 2020

Effects of aminoglutethimide on adrenal steroid secretion

1 reference

12 December 2020

The influence of intramuscular 4-hydroxyandrostenedione on peripheral aromatisation in breast cancer patients

1 reference

12 December 2020

Efficacy and tolerability of 4-hydroxyandrostenedione (4-OHA) as first-line treatment in postmenopausal patients with breast cancer after adjuvant therapy.

1 reference

12 December 2020

Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and route

1 reference

12 December 2020

Mechanisms of action of aminoglutethimide as endocrine therapy of breast cancer

1 reference

12 December 2020

4-hydroxyandrostenedione: a new treatment for postmenopausal patients with breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00685855

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7781147%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

1 reference